STEPHANIE MARLIN: Open Payments
NPI 1649705500 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,188 in 178 payments from 20 companies in 2025. Trend: 2023 $5,777 · 2024 $15,301 · 2025 $7,188
Speaker / faculty: $3,825Food & beverage: $3,128Travel & lodging: $136Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $4,582 |
| Janssen Biotech, Inc. | 38 | $670 |
| Novartis Pharmaceuticals Corporation | 22 | $445 |
| PFIZER INC. | 10 | $228 |
| LEO Pharma Inc. | 8 | $193 |
| Amgen Inc. | 6 | $136 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $115 |
| Incyte Corporation | 4 | $114 |
| GENZYME CORPORATION | 3 | $108 |
| UCB, Inc. | 4 | $106 |
Products named: RINVOQ, TREMFYA, COSENTYX, SKYRIZI, CIBINQO, ADBRY, OTEZLA, OPZELURA.
Industry payments across RI — which companies pay providers there.
